Imunon, Inc. Faces Delisting Concerns
Ticker: IMNN · Form: 8-K · Filed: Aug 28, 2025 · CIK: 749647
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Imunon might get delisted, big trouble for the stock.
AI Summary
Imunon, Inc. filed an 8-K on August 27, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as Celsion Corp, is incorporated in Delaware and headquartered in Lawrenceville, NJ.
Why It Matters
This filing indicates potential issues with Imunon, Inc.'s continued listing on an exchange, which could significantly impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued operation and stock viability.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- Celsion Corp (company) — Former company name
- August 27, 2025 (date) — Date of earliest event reported
- Lawrenceville, NJ (location) — Company business address
FAQ
What specific listing rule or standard has Imunon, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Imunon, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is August 27, 2025.
What were Imunon, Inc.'s former company names?
Imunon, Inc. was formerly known as Celsion Corp (name change on November 21, 2007, and May 15, 1998) and Cheung Laboratories Inc (name change on July 3, 1992).
Where is Imunon, Inc. incorporated and what is its business address?
Imunon, Inc. is incorporated in Delaware and its business address is 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648.
What is the Commission File Number for Imunon, Inc.?
The Commission File Number for Imunon, Inc. is 001-15911.
Filing Stats: 451 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-08-28 08:08:33
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share IMNN Nasdaq Capital Mark
- $1.00 m — ompany has regained compliance with the $1.00 minimum closing bid price requirement for
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 8KB
- 0001493152-25-012417.txt ( ) — 230KB
- imnn-20250827.xsd (EX-101.SCH) — 3KB
- imnn-20250827_lab.xml (EX-101.LAB) — 33KB
- imnn-20250827_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMUNON, INC. Dated: August 28, 2025 By: /s/ Susan Eylward Susan Eylward General Counsel and Corporate Secretary